Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Current Topics in Medicinal Chemistry|February 10, 2022
Privileged Scaffolds Targeting Bromodomain-containing Protein 4Ru Wang, Yi-Ang Wang, Yun-Gen Xu, et al.
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|May 24, 2007
[Synthesis and bioactivity of N- [4- ( benzimidazole-2-thio) phenyl] -N'-alkyl guanidine derivatives]Yun-gen Xu, Ai-min Xing, Min Hong, et al.
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|November 23, 2006
[Synthesis and bioactivity of 2-arylimino-4-thiazolidones]Da-yong Zhang, Hua Xiang, Yun-gen Xu, et al.
Archiv Der Pharmazie|November 29, 2014
Design, synthesis, and evaluation of non-ATP-competitive small-molecule Polo-like kinase 1 (Plk1) inhibitorsDong-Xing Chen, Jie Huang, Meng Liu, et al.
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|November 25, 2003
[Synthesis and nNOS inhibitory activity of benzenealkyl isothiourea compounds]Yun-gen Xu, Jing-xin Zhang, Wei-yi Hua, et al.
Bioorganic & Medicinal Chemistry Letters|March 10, 2007
Benzimidazol-2-yl or benzimidazol-2-ylthiomethyl benzoylguanidines as novel Na+/H+ exchanger inhibitors, synthesis and protection against ischemic-reperfusion injuryRui Zhang, Lin Lei, Yun-Gen Xu, et al.
European Journal of Medicinal Chemistry|July 28, 2014
Discovery of N-(2-phenyl-1H-benzo[d]imidazol-5-yl)quinolin-4-amine derivatives as novel VEGFR-2 kinase inhibitorsLei Shi, Ting-Ting Wu, Zhi Wang, et al.
Bioorganic & Medicinal Chemistry|August 2, 2014
Discovery of quinazolin-4-amines bearing benzimidazole fragments as dual inhibitors of c-Met and VEGFR-2Lei Shi, Ting-Ting Wu, Zhi Wang, et al.
Expert Opinion on Therapeutic Patents|June 17, 2017
VEGFR-2 inhibitors and the therapeutic applications thereof: a patent review (2012-2016)Fan-Wei Peng, Da-Ke Liu, Qing-Wen Zhang, et al.
European Journal of Medicinal Chemistry|June 2, 2009
Synthesis and bioactivity of substituted indan-1-ylideneaminoguanidine derivativesRui Zhang, Jin Dong, Yun-gen Xu, et al.
Pageof 4